{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:12:37Z","timestamp":1788865957030,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"DOI":"10.1038\/s41366-026-02212-1","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:57:26Z","timestamp":1788865046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intestinal HIF1\u03b1 is dispensable for bariatric surgery-mediated metabolic benefits but protects against diet-induced obesity and hepatic steatosis"],"prefix":"10.1038","author":[{"given":"Chong","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhuo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Jaime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengcheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1466-752X","authenticated-orcid":false,"given":"Yikai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"2212_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s13679-025-00637-9","volume":"14","author":"C Koliaki","year":"2025","unstructured":"Koliaki C, Dalamaga M, Kakounis K, Liatis S. Metabolically healthy obesity and metabolic dysfunction-associated steatotic liver disease (MASLD): navigating the controversies in disease development and progression. Curr Obes Rep. 2025;14:46 https:\/\/doi.org\/10.1007\/s13679-025-00637-9.","journal-title":"Curr Obes Rep"},{"key":"2212_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"European Association for the Study of the L","year":"2024","unstructured":"European Association for the Study of the LEuropean Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81:492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031.","journal-title":"J Hepatol"},{"key":"2212_CR3","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","volume":"159","author":"G Lassailly","year":"2020","unstructured":"Lassailly G, Caiazzo R, Ntandja-Wandji LC, Gnemmi V, Baud G, Verkindt H, et al. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology. 2020;159:1290\u2013301 e5. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.006.","journal-title":"Gastroenterology"},{"key":"2212_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.metabol.2019.07.002","volume":"99","author":"N Cabre","year":"2019","unstructured":"Cabre N, Luciano-Mateo F, Fernandez-Arroyo S, Baiges-Gaya G, Hernandez-Aguilera A, Fibla M, et al. Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation. Metabolism. 2019;99:81\u201389. https:\/\/doi.org\/10.1016\/j.metabol.2019.07.002.","journal-title":"Metabolism"},{"key":"2212_CR5","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1074\/jbc.REV120.011188","volume":"295","author":"R Singhal","year":"2020","unstructured":"Singhal R, Shah YM. Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine. J Biol Chem. 2020;295:10493\u2013505. https:\/\/doi.org\/10.1074\/jbc.REV120.011188.","journal-title":"J Biol Chem"},{"key":"2212_CR6","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 2015;17:662\u201371. https:\/\/doi.org\/10.1016\/j.chom.2015.03.005.","journal-title":"Cell Host Microbe"},{"key":"2212_CR7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.it.2021.05.004","volume":"42","author":"LP Pral","year":"2021","unstructured":"Pral LP, Fachi JL, Correa RO, Colonna M, Vinolo MAR. Hypoxia and HIF-1 as key regulators of gut microbiota and host interactions. Trends Immunol. 2021;42:604\u201321. https:\/\/doi.org\/10.1016\/j.it.2021.05.004.","journal-title":"Trends Immunol"},{"key":"2212_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.609689","volume":"11","author":"YI Kim","year":"2020","unstructured":"Kim YI, Yi EJ, Kim YD, Lee AR, Chung J, Ha HC, et al. Local stabilization of hypoxia-inducible factor-1alpha controls intestinal inflammation via enhanced gut barrier function and immune regulation. Front Immunol. 2020;11:609689. https:\/\/doi.org\/10.3389\/fimmu.2020.609689.","journal-title":"Front Immunol"},{"key":"2212_CR9","doi-asserted-by":"publisher","first-page":"9983","DOI":"10.1039\/d4fo02283a","volume":"15","author":"H Ma","year":"2024","unstructured":"Ma H, Wang Y, Wei J, Wang X, Yang H, Wang S. Stabilization of hypoxia-inducible factor 1alpha and regulation of specific gut microbes by EGCG contribute to the alleviation of ileal barrier disorder and obesity. Food Funct. 2024;15:9983\u201394. https:\/\/doi.org\/10.1039\/d4fo02283a.","journal-title":"Food Funct"},{"key":"2212_CR10","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.jhep.2018.05.021","volume":"69","author":"T Shao","year":"2018","unstructured":"Shao T, Zhao C, Li F, Gu Z, Liu L, Zhang L, et al. Intestinal HIF-1alpha deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction. J Hepatol. 2018;69:886\u201395. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.021.","journal-title":"J Hepatol"},{"key":"2212_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1126\/science.aba3683","volume":"373","author":"W Yoo","year":"2021","unstructured":"Yoo W, Zieba JK, Foegeding NJ, Torres TP, Shelton CD, Shealy NG, et al. High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide. Science. 2021;373:813\u20138. https:\/\/doi.org\/10.1126\/science.aba3683.","journal-title":"Science"},{"key":"2212_CR12","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg H, Adolph TE, Trauner M. Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab. 2022;34:1700\u201318. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.017.","journal-title":"Cell Metab"},{"key":"2212_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.cmet.2018.06.004","volume":"28","author":"D Ben-Zvi","year":"2018","unstructured":"Ben-Zvi D, Meoli L, Abidi WM, Nestoridi E, Panciotti C, Castillo E, et al. Time-dependent molecular responses differ between gastric bypass and dieting but are conserved across species. Cell Metab. 2018;28:310\u201323 e6. https:\/\/doi.org\/10.1016\/j.cmet.2018.06.004.","journal-title":"Cell Metab"},{"key":"2212_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110270","volume":"38","author":"SS Evers","year":"2022","unstructured":"Evers SS, Shao Y, Ramakrishnan SK, Shin JH, Bozadjieva-Kramer N, Irmler M, et al. Gut HIF2alpha signaling is increased after VSG, and gut activation of HIF2alpha decreases weight, improves glucose, and increases GLP-1 secretion. Cell Rep. 2022;38:110270. https:\/\/doi.org\/10.1016\/j.celrep.2021.110270.","journal-title":"Cell Rep"},{"key":"2212_CR15","doi-asserted-by":"publisher","unstructured":"Recena Aydos L, Aparecida do Amaral L, Serafim de Souza R, Jacobowski AC, Freitas Dos, Santos E, et al. Nonalcoholic fatty liver disease induced by high-fat diet in C57bl\/6 models. Nutrients. 2019;11. https:\/\/doi.org\/10.3390\/nu11123067.","DOI":"10.3390\/nu11123067"},{"key":"2212_CR16","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/hep.31897","volume":"74","author":"YR Im","year":"2021","unstructured":"Im YR, Hunter H, de Gracia Hahn D, Duret A, Cheah Q, Dong J, et al. A Systematic Review of Animal Models of NAFLD Finds High-Fat, High-Fructose Diets Most Closely Resemble Human NAFLD. Hepatology. 2021;74:1884\u2013901. https:\/\/doi.org\/10.1002\/hep.31897.","journal-title":"Hepatology"},{"key":"2212_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1091040","volume":"14","author":"C Cao","year":"2023","unstructured":"Cao C, Tan X, Yan H, Shen Q, Hua R, Shao Y, et al. Sleeve gastrectomy decreases high-fat diet induced colonic pro-inflammatory status through the gut microbiota alterations. Front Endocrinol (Lausanne). 2023;14:1091040. https:\/\/doi.org\/10.3389\/fendo.2023.1091040.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2212_CR18","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.7150\/ijbs.86717","volume":"19","author":"X Shao","year":"2023","unstructured":"Shao X, Liu L, Zhou Y, Zhong K, Gu J, Hu T, et al. High-fat diet promotes colitis-associated tumorigenesis by altering gut microbial butyrate metabolism. Int J Biol Sci. 2023;19:5004\u201319. https:\/\/doi.org\/10.7150\/ijbs.86717.","journal-title":"Int J Biol Sci"},{"key":"2212_CR19","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.cmet.2022.09.024","volume":"34","author":"JH Shin","year":"2022","unstructured":"Shin JH, Bozadjieva-Kramer N, Shao Y, Lyons-Abbott S, Rupp AC, Sandoval DA, et al. The gut peptide Reg3g links the small intestine microbiome to the regulation of energy balance, glucose levels, and gut function. Cell Metab. 2022;34:1765\u201378 e6. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.024.","journal-title":"Cell Metab"},{"key":"2212_CR20","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1053\/j.gastro.2018.11.017","volume":"156","author":"VL Albaugh","year":"2019","unstructured":"Albaugh VL, Banan B, Antoun J, Xiong Y, Guo Y, Ping J, et al. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery. Gastroenterology. 2019;156:1041\u201351 e4. https:\/\/doi.org\/10.1053\/j.gastro.2018.11.017.","journal-title":"Gastroenterology"},{"key":"2212_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature13135","volume":"509","author":"KK Ryan","year":"2014","unstructured":"Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014;509:183\u20138. https:\/\/doi.org\/10.1038\/nature13135.","journal-title":"Nature"},{"key":"2212_CR22","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.soard.2016.02.029","volume":"12","author":"J Vidal","year":"2016","unstructured":"Vidal J, de Hollanda A, Jimenez A. GLP-1 is not the key mediator of the health benefits of metabolic surgery. Surg Obes Relat Dis. 2016;12:1225\u20139. https:\/\/doi.org\/10.1016\/j.soard.2016.02.029.","journal-title":"Surg Obes Relat Dis"},{"key":"2212_CR23","doi-asserted-by":"publisher","unstructured":"Xu M, Taylor MS, Hill BG, Li X, Rouchka EC, McClain CJ, et al. Intestine epithelial-specific hypoxia-inducible factor-1alpha overexpression ameliorates western diet-induced MASLD. Hepatol Commun. 2024;8. https:\/\/doi.org\/10.1097\/HC9.0000000000000572.","DOI":"10.1097\/HC9.0000000000000572"},{"key":"2212_CR24","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1007\/DCR.0b013e3181f1e620","volume":"53","author":"F Rowan","year":"2010","unstructured":"Rowan F, Docherty NG, Murphy M, Murphy B, Calvin Coffey J, O\u2019Connell PR. Desulfovibrio bacterial species are increased in ulcerative colitis. Dis Colon Rectum. 2010;53:1530\u20136. https:\/\/doi.org\/10.1007\/DCR.0b013e3181f1e620.","journal-title":"Dis Colon Rectum"},{"key":"2212_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01722-8","volume":"12","author":"R Xie","year":"2024","unstructured":"Xie R, Gu Y, Li M, Li L, Yang Y, Sun Y, et al. Desulfovibrio vulgaris interacts with novel gut epithelial immune receptor LRRC19 and exacerbates colitis. Microbiome. 2024;12:4. https:\/\/doi.org\/10.1186\/s40168-023-01722-8.","journal-title":"Microbiome"},{"key":"2212_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2442038","volume":"17","author":"S Zhao","year":"2025","unstructured":"Zhao S, Wu W, Song W, Zhou Q, Cheng H, Deng S, et al. Microbial perspective of multidisciplinary collaborative weight management approach: ruminococcus gnavus may serve as a key target for weight loss. Gut Microbes. 2025;17:2442038. https:\/\/doi.org\/10.1080\/19490976.2024.2442038.","journal-title":"Gut Microbes"},{"key":"2212_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nchembio.1864","volume":"11","author":"AS Devlin","year":"2015","unstructured":"Devlin AS, Fischbach MA. A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat Chem Biol. 2015;11:685\u201390. https:\/\/doi.org\/10.1038\/nchembio.1864.","journal-title":"Nat Chem Biol"},{"key":"2212_CR28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-021-03832-5","volume":"599","author":"Y Sato","year":"2021","unstructured":"Sato Y, Atarashi K, Plichta DR, Arai Y, Sasajima S, Kearney SM, et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature. 2021;599:458\u201364. https:\/\/doi.org\/10.1038\/s41586-021-03832-5.","journal-title":"Nature"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02212-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02212-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02212-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:57:26Z","timestamp":1788865046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02212-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":28,"alternative-id":["2212"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02212-1","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The animal experiments in this study were conducted in accordance with institutional guidelines and were approved by the Department of Laboratory Animal Science, Fudan University (protocol 2019 Huashan Hospital JS-161). All experiments complied with the 3R principles.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}